T Cell Deficiency
The primary end-point of our prospective, observational study is to count T cells in patients with laboratory-confirmed COVID-19 and healthy controls.
AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.
Free account
You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.